0049sek
3,4 %
Date:2025-05-14Time:16:03:03Latest report:Q3-2024List:First NorthTicker:GABA
Market Cap:12 msekEnterprise Value:9 msekNet Sales:- msekEarnings:-9,23 msekEmployees:0ISIN:SE0010869552

Ratios

10-year key figure history for Gabather turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Gabather with index and moving average MA50 and MA200.

Stockprice:0,049
MA50:0,05
MA200:0,38
Price/MA200:-87,2 %
RSI (14):60,5
Price/MA50:-5,0 %

Description

Gabather is a pharmaceutical company. Today, there is a business focus on developing drug candidates for the treatment of nerve diseases. Particular focus is on the stimulation of gamma-aminobutyric acid, which is the main inhibitory neurotransmitter in the brain. The drug candidates are today patented on a global level. Gabather was established in 2014 and is headquartered in Malmö.

Biotechnology